Physician
Emergency Medicine
Dr. Daniel M. Bissell, MD
|
|
Give Review
Daniel Bissell practices Emergency Medicine. He researched medicine at University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is one of the top medical schools in the US. University of Colorado Denver School of Medicine is ranked 35 in research and 8 in primary care medicine Daniel Bissell is a published doctor. He has 33 publications published. The most current publication "Hepatic fibrosis as wound repair: a progress report." Daniel Bissell is registered with Medicare.
Publications
- Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias.
- Role of delta-Aminolevulinic Acid in the Symptoms of Acute Porphyria.
- Loss-of-Function Ferrochelatase and Gain-of-Function Erythroid 5-Aminolevulinate Synthase Mutations Causing Erythropoietic Protoporphyria and X-Linked Protoporphyria i...
- Fibronectin transcription in liver cells: promoter occupation and function in sinusoidal endothelial cells and hepatocytes.
- Attenuated response to liver injury in moesin-deficient mice: impaired stellate cell migration and decreased fibrosis.
- Role of alphavbeta6 integrin in acute biliary fibrosis.
- Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice.
- Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.
- Noninvasive measures of liver fibrosis.
- Hepatology over the years.
- TWEAK induces liver progenitor cell proliferation.
- Role of CD44 in epithelial wound repair: migration of rat hepatic stellate cells utilizes hyaluronic acid and CD44v6.
- Regulation of fibronectin splicing in sinusoidal endothelial cells from normal or injured liver.
- Assessing fibrosis without a liver biopsy: are we there yet?
- Of mentors, mentoring, and extracellular matrix.
- Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation.
- Inflammation and hepatic fibrosis.
- Therapy for hepatic fibrosis: revisiting the preclinical models.
- The origin of hepatic myofibroblasts. Mak KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells [Gastroenterology...
- Chronic liver injury, TGF-beta, and cancer.
- International hepatology.
- Transforming growth factor beta and the liver.
- Drug-induced liver injury: mechanisms and test systems.
- Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference.
- Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.
- In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis.
- Evidence for a role of the alternatively spliced ED-I sequence of fibronectin during ovarian follicular development.
- Sex and hepatic fibrosis.
- Clinical research funding and GI organizations.
- Hepatic fibrosis as wound repair: a progress report.
- Porphyria and porphyrinology--the past fifteen years.
- Two novel antifibrotics, HOE 077 and Safironil, modulate stellate cell activation in rat liver injury: differential effects in males and females.
Schools
UNIVERSITY OF COLORADO AT DENVER
Doctors Specialties
- Emergency Medicine
Accepted Insurances
- Aetna
- Assurant Health
- Blue Card PPO
- Cigna
- Commercial Insurance Company
- First Choice Health PPO
- GEHA
- Medicare Advantage PFFS
- HealthSmart
- Humana
- Kaiser Permanente
- MedHealthInsurance
- Medicaid
- Medicare MCR
- Molina
- ODS Health Plan
- PacificSource
- Providence Health Plans
- United Healthcare
Education
-
Maine Medical Center -
University of Colorado Denver School of Medicine
Drug Facts
| NPI NUMBER | 1093737058 | |
| NPPES Provider LastName | BISSELL | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 986862742 | |
| NPPES Provider State | WA | |
| Specialty Description | Emergency Medicine | |
| Total Claim Count | 243.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 22.0 | |
| Percent Opioid Claims | 9.05 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093737058 |
| Last Name Of The Provider | BISSELL |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Mark R. Anderson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gail H. Jacobson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George T. Lin, MD |
|
|
Dr. Jonathan T. Claud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason D. Hanley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Darrell M. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Loyal D. Marsh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita J. Demlow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cameron D. Mitchell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert F. Sapp, MD |